A federal appeals court has significantly restricted access to mifepristone , a common abortion medication, by blocking its distribution through the mail. A panel from the New Orleans -based 5th U.S. Circuit Court of Appeals now requires the abortion pill to be dispensed solely in person at clinics. The ruling asserted: "Every abortion facilitated by FDA ’s action cancels Louisiana’s ban on medical abortions and undermines its policy that ‘every unborn child is human being from the moment of conception and is, therefore, a legal person.’" This decision diverges from the historical judicial deference to the Food and Drug Administration's judgments on drug safety and regulation. Mifepristone was approved in 2000 as a safe and effective way to end early pregnancies (AP Photo/Charlie Riedel) FDA officials under President Donald Trump have repeatedly stated the agency is conducting a new review of mifepristone’s safety, at the direction of the president.…